Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 412

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 412
---
 $ |    358,181 | ​ | ​ | ​ | ​                                   | $ |     337,721 | ​ | ​ |
| Supplemental disclosure of non – cash operating and financing activities:   | ​ | ​ | ​                                   | ​ |          ​ | ​ | ​ | ​ | ​                                   | ​ |           ​ | ​ | ​ |
| Conversion of Class B common stock to Class A common stock                  | ​ | ​ | ​                                   | $ |          — | ​ | ​ | ​ | ​                                   | $ |         690 | ​ | ​ |
| Remeasurement of Class A common stock subject to redemptionvalue            | ​ | ​ | ​                                   | $ |    205,382 | ​ | ​ | ​ | ​                                   | $ |     479,371 | ​ | ​ |
| Excise tax                                                                  | ​ | ​ | ​                                   | $ |     18,029 | ​ | ​ | ​ | ​                                   | $ |     103,587 | ​ | ​ |
| Income taxes paid                                                           | ​ | ​ | ​                                   | $ |    375,894 | ​ | ​ | ​ | ​                                   | $ |     193,845 | ​ | ​ |
| Recovery of excess redemptions – tax claim                                  | ​ | ​ | ​                                   | $ |    294,669 | ​ | ​ | ​ | ​                                   | $ |           — | ​ | ​ |
| Deemed contribution for extension deposit from related party                | ​ | ​ | ​                                   | $ |    117,669 | ​ | ​ | ​ | ​                                   | $ |           — | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-5

TABLE OF CONTENTS

### IRIS ACQUISITION CORP

### NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

### NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Iris Acquisition Corp (the “Company”) formally known as Tribe Capital Growth Corp I (name of the Company was changed on July 27, 2022), is a blank check company incorporated in Delaware on November 5, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

As of September